A fibrous wound dressing comprising a formulation of amphiphilic antiseptic and separate surfactants is provided.

An anti-infective protective device including a cap member and a connector ring member. The cap member includes an enclosed pad having a disinfectant solution immersed therein, which is sealed in the cap member by a covering attached to the cap member. The cap member disinfects and covers a received port attached which is attached to a tubing element. The connector ring member is attached to at least one tubing element at one end and is attached to the cap member at an opposite end. The connector ring member integrates the cap member with a structure of the tubing element.

Described herein are compositions and methods of use thereof for treatment of musculoskeletal disorders by way of administering at least one galectin inhibitor to a subject, such as galactoarabino-rhamnogalacturonan (GR) and derivatives thereof, and galactomannan (GM) and derivatives thereof. In particular embodiments the described compounds are administered in combination with hyaluronic acid or Chitosan.

Antimicrobial catheters and medical devices are provided. In some aspects, a low durometer aliphatic polyether polyurethane may be impregnated with a first antimicrobial agent (e.g., minocycline and rifampin) and coated with a second antimicrobial agent (e.g., chlorhexidine, gendine, or gardine). The antimicrobial catheters may display improved flexibility and resistance to kinking. Methods of producing the antimicrobial catheters are also provided.

Antimicrobial silicone-based dressings, such as wound dressings, are disclosed. An example dressing comprises a transparent and self-adhesive gel sheet cured from a liquid containing silicone, the sheet having dispersed therein (i) particulates of a chlorhexidine compound that is not soluble in the liquid; and (ii) at least one other antimicrobial. Methods of making the silicone-based dressings and methods of use are also disclosed.

According to one embodiment, an absorbent article includes a moisture-impervious outer layer, an inner layer substantially co-extensive with the outer layer, and an absorbent layer interposed between the outer layer and the inner layer. The inner layer is treated with at least one antimicrobial booster. The absorbent layer is treated with at least one antimicrobial agent.

Antimicrobial catheters and medical devices are provided. In some aspects, a low durometer aliphatic polyether polyurethane may be impregnated with a first antimicrobial agent (e.g., minocycline and rifampin) and coated with a second antimicrobial agent (e.g., chlorhexidine, gendine, or gardine). The antimicrobial catheters may display improved flexibility and resistance to kinking. Methods of producing the antimicrobial catheters are also provided.

An absorbable, biocompatible barbed microcatheter for delivering therapeutic fluids to a patient includes a hollow tube having an elongated lumen that extends between proximal and distal ends of the hollow tube, a plurality of barbs projecting from the hollow tube, and a plurality of fluid egress openings formed in the hollow tube that are in fluid communication with the elongated lumen. The fluid egress openings are evenly spaced from one another along the length of the hollow tube. An anchor is secured to the proximal end of the hollow tube, and a surgical needle is secured to the distal end of the hollow tube. Two or more of the fluid egress openings formed in the hollow tube have different sizes so that a first fluid egress opening located adjacent the anchor is larger than a second fluid egress opening adjacent the surgical needle.

An acellular dermal matrix (ADM) graft product includes an ADM graft derived from full-thickness skin, with a pre-formed shape having a mesh pattern formed therein. The ADM graft is disposed in a sterilization package and irradiated to provide a two year shelf-life for the ADM graft product, which is used in the time-saving, efficient, and effective surgical reconstruction of soft tissue defects. One manufacturing method involves providing a portion of full-thickness donor-derived skin, removing an epidermis and a fat layer form the portion of the skin, decellularizing the portion of the skin to form a portion of ADM graft material, pre-shaping and meshing the ADM graft material, verifying a thickness of the ADM graft material, and packaging the pre-shaped, meshed ADM graft material in a sterilizable package and irradiating for a two-year shelf-life to form the ADM graft product. Other embodiments are also disclosed.

A medical device adapted for contact with a vessel or cavity in the body including a tubular portion is provided. The device has an external surface including an external substance that is at least one of a coating or an impregnation, comprising alexidine in an amount that is both anti thrombogenically effective and anti microbially effective. The device also has an internal surface including an internal substance that is at least one of a coating or an impregnation, comprising alexidine in an amount that is both anti thrombogenically effective and anti microbially effective.